Yuan; Ta-Tung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yuan; Ta-Tung.The latest application filed is for "antibodies specific to alpha-enolase and uses thereof".

Company Profile

3.10.11

Yuan; Ta-Tung - New Taipei TW
Yuan; Ta-Tung - Xizhi TW
YUAN; TA-TUNG - NEW TAIPEI CITY TW
Yuan; Ta-Tung - San Marino CA
Yuan; Ta-Tung - Xizhi City TW
Yuan; Ta Tung - Taipei TW
Yuan; Ta-Tung - Cupertino CA
Yuan; Ta-Tung - Galveston TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies specific to alpha-enolase and uses thereof Grant 10,781,266 - Tsai , et al. Sept	2020-09-22
Polysaccharide conjugation with detoxified E. coli heat labile enterotoxin (LT) used as vaccine Grant 10,624,962 - Hsu , et al.	2020-04-21
Antibodies Specific To Alpha-enolase And Uses Thereof App 20190322762 - TSAI; SHIH-CHONG ; et al.	2019-10-24
Site-specific Conjugation Through Glycoproteins Linkage And Method Thereof App 20170369525 - Lee; Chao-Pin ; et al.	2017-12-28
Alpha-enolase specific antibodies and method of use in immune diseases Grant 9,750,804 - Tsai , et al. September 5, 2	2017-09-05
Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy Grant 9,527,922 - Tsai , et al. December 27, 2	2016-12-27
Alpha-enolase specific antibodies and methods of uses in cancer therapy Grant 9,382,331 - Tsai , et al. July 5, 2	2016-07-05
Humanized Alpha-enolase Specific Antibodies And Methods Of Uses In Cancer Therapy App 20160185876 - Tsai; Shih-Chong ; et al.	2016-06-30
Alpha-enolase Specific Antibodies And Methods Of Uses In Cancer Therapy App 20150183884 - Tsai; Shih-Chong ; et al.	2015-07-02
Alpha-enolase Specific Antibodies And Method Of Use In Immune Diseases App 20150175710 - Tsai; Shih-Chong ; et al.	2015-06-25
Bispecific T-cell activator antibody Grant 8,961,971 - Hsu , et al. February 24, 2	2015-02-24
Bispecific T-cell Activator Antibody App 20130165629 - Hsu; Yu-Shen ; et al.	2013-06-27
Mutated E. coli heat-labile enterotoxin Grant 8,110,197 - Hsu , et al. February 7, 2	2012-02-07
Mutated E. coli heat-labile enterotoxin Grant 8,088,394 - Hsu , et al. January 3, 2	2012-01-03
POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. coli HEAT LABILE ENTEROTOXIN (LT) USED AS VACCINE App 20110274717 - Hsu; Yu-Shen ; et al.	2011-11-10
Il-1ra-polymer Conjugates App 20110097302 - Yuan; Ta Tung ; et al.	2011-04-28
Mutated E. Coli Heat-labile Enterotoxin App 20080220519 - Hsu; Yu-Shen ; et al.	2008-09-11
Mutated E. Coli Heat-labile Enterotoxin App 20080102078 - Hsu; Yu-Shen ; et al.	2008-05-01
Novel prostate tumor-specific promoter App 20060188990 - Kretschmer; PeterJ ; et al.	2006-08-24
Viral defective interfering particles and uses thereof Grant 5,980,901 - Shih , et al. November 9, 1	1999-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.